Lapidar 5 Tab 14 mg Tablet is a Health Canada–registered human drug (DIN 00445320) held by Swiss Herbal Remedies Ltd., containing Equisetum Arvense. Health Canada lists its status as Cancelled Post Market (status date 02 Dec 1999). Nexara Health has matched 4 registrations of Equisetum Arvense across 3 other regulated markets.
Health Canada registration
| DIN | 00445320 |
|---|---|
| Brand name | Lapidar 5 Tab |
| Active ingredient | Equisetum Arvense |
| Strength | 14 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Swiss Herbal Remedies Ltd. |
| Status | Cancelled Post Market — 02 Dec 1999 |
| Class | Human |
| ATC | |
| AHFS | 92:01.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Equisetum Arvense registered in other markets
4 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | DSY Horsetail Extract 500mg Capsule | Cta Nutriceuticals (Asia) Sdn Bhd | Natural Product | PRODUCT APPROVED | NPRA | |
| Netherlands | Equisetum arvense | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Equisetum arvense | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Equisetum arvense | Herbamed AG | Liquid | FDA NDC |
See every manufacturer of Equisetum Arvense worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Lapidar 5 Tab (DIN 00445320) marketed in Canada?
No. Health Canada lists DIN 00445320 as Cancelled Post Market as of 02 Dec 1999.
Who holds the Canadian licence for this product?
Swiss Herbal Remedies Ltd. is the company of record in the Health Canada Drug Product Database.
Is Equisetum Arvense registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00445320, status date 1999-12-02; national medicine registries: EU national register, FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00445320, status date 1999-12-02; national medicine registries: EU national register, FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 00445320, status date 1999-12-02; national medicine registries: EU national register, FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.